NeueHealth Correlations
NEUE Stock | 6.38 0.09 1.43% |
The correlation of NeueHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeueHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeueHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between NeueHealth and NYA is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeueHealth and NYA in the same portfolio, assuming nothing else is changed.
NeueHealth |
The ability to find closely correlated positions to NeueHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeueHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeueHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeueHealth to buy it.
Moving together with NeueHealth Stock
0.63 | ELOX | Eloxx Pharmaceuticals | PairCorr |
0.63 | ENZN | Enzon Pharmaceuticals Earnings Call This Week | PairCorr |
0.67 | EVLO | Evelo Biosciences Financial Report 20th of May 2024 | PairCorr |
Moving against NeueHealth Stock
0.57 | ELTP | Elite Pharma | PairCorr |
0.46 | ENGN | enGene Holdings Common | PairCorr |
0.52 | NGM | NGM Biopharmaceuticals Earnings Call Tomorrow | PairCorr |
0.43 | ATR | AptarGroup Earnings Call Today | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NeueHealth Stock performing well and NeueHealth Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeueHealth's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
OSCR | 3.25 | 0.64 | 0.19 | 1.16 | 2.86 | 7.48 | 33.77 | |||
CLOV | 2.62 | (0.52) | 0.00 | 5.17 | 0.00 | 5.19 | 16.19 | |||
YCBD-PA | 3.39 | 0.20 | 0.03 | (0.47) | 3.48 | 9.21 | 35.84 | |||
ENGN | 4.78 | 1.47 | 0.44 | 0.31 | 3.01 | 5.04 | 126.51 | |||
EPRX | 3.32 | (0.47) | 0.00 | (0.52) | 0.00 | 12.31 | 14.98 | |||
CEROW | 19.40 | 3.36 | 0.17 | (3.43) | 15.57 | 53.14 | 139.50 | |||
FBLG | 9.13 | (0.39) | 0.00 | 0.11 | 0.00 | 16.02 | 118.46 | |||
ATR | 0.68 | 0.16 | 0.14 | 1.24 | 0.61 | 1.83 | 6.73 | |||
STRRP | 0.85 | (0.05) | 0.00 | 0.50 | 0.00 | 2.11 | 8.22 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in NeueHealth without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
NeueHealth Corporate Management
Elected by the shareholders, the NeueHealth's board of directors comprises two types of representatives: NeueHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NeueHealth. The board's role is to monitor NeueHealth's management team and ensure that shareholders' interests are well served. NeueHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NeueHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Craig | General Secretary | Profile | |
Jeffrey Scherman | Chief Officer | Profile | |
Jay Matushak | Chief Officer | Profile | |
Tomas Orozco | Executive Care | Profile |
Already Invested in NeueHealth?
The danger of trading NeueHealth is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of NeueHealth is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than NeueHealth. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile NeueHealth is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Transaction History View history of all your transactions and understand their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is NeueHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.